Large-scale testing (Phase 3)Active Not RecruitingNCT05210790What this trial is testingRusfertide in Patients With Polycythemia VeraWho this might be right forPolycythemia Vera Protagonist Therapeutics, Inc. 293
Testing effectiveness (Phase 2)Study completedNCT00448357What this trial is testingAllogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based RegimenWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more UNC Lineberger Comprehensive Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00002504What this trial is testingInterleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Hoag Memorial Hospital Presbyterian
Large-scale testing (Phase 3)Study completedNCT01969838What this trial is testingMomelotinib Versus Ruxolitinib in Subjects With MyelofibrosisWho this might be right forPrimary MyelofibrosisPost-Polycythemia Vera MyelofibrosisPost-Essential Thrombocythemia Myelofibrosis Sierra Oncology LLC - a GSK company 432
Large-scale testing (Phase 3)Study completedNCT06002490What this trial is testingEvaluate P1101 in Japanese PV PatientsWho this might be right forPolycythemia Vera (PV) PharmaEssentia Japan K.K. 21
Testing effectiveness (Phase 2)Study completedNCT00245037What this trial is testingBusulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 147
Not applicableUnknownNCT02897297What this trial is testingMyeloproliferative Neoplastic Diseases Observatory From BrestWho this might be right forPolycythemia VeraEssential ThrombocythemiaPrimary Myelofibrosis University Hospital, Brest 1,000
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Large-scale testing (Phase 3)Active Not RecruitingNCT05481151What this trial is testingAssess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PVWho this might be right forPolycythemia Vera PharmaEssentia 111
Not applicableLooking for participantsNCT05396170What this trial is testingEffect of Phlebotomy on Heartrate in Polycythemia PatientsWho this might be right forPolycythemia Leiden University Medical Center 10
Not applicableStudy completedNCT00453206What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Wake Forest University Health Sciences 66
Not applicableNot Yet RecruitingNCT07282132What this trial is testingEvaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter StudyWho this might be right forPolycytemia Vera Federico II University 150
Large-scale testing (Phase 3)Study completedNCT04173494What this trial is testingMomelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM)Who this might be right forPrimary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis Sierra Oncology LLC - a GSK company 195
Testing effectiveness (Phase 2)Ended earlyNCT01790295What this trial is testingRuxolitinib Prior to Transplant in Patients With MyelofibrosisWho this might be right forPrimary MyelofibrosisPost Polycythemia Vera MyelofibrosisPost Essential Thrombocythemia Myelofibrosis John Mascarenhas 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03669965What this trial is testingKRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia VeraWho this might be right forPolycythemia Vera Kartos Therapeutics, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT03194542What this trial is testingA Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion DependenceWho this might be right forPrimary MyelofibrosisAnemia Celgene 95
Not applicableUnknownNCT05883904What this trial is testingReal World Evidence of Fedratinib Effectiveness in MFWho this might be right forPrimary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis Gruppo Italiano Malattie EMatologiche dell'Adulto 93
Not applicableLooking for participantsNCT06734637What this trial is testingEfficacy and Safety of Peginterferon in ET and PV.Who this might be right forEssential ThrombocythemiaPolycythemia Vera Zhenya Hong 40
Not applicableStudy completedNCT06752941What this trial is testingLOW-PV ContinuationWho this might be right forPolycythemia Vera FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS 36
Testing effectiveness (Phase 2)Study completedNCT02742324What this trial is testingTrial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPegWho this might be right forMyelofibrosis French Innovative Leukemia Organisation 37